Search
for
Sort by
Research 961–990 of 1000+
- Polycystic Ovarian Syndrome - What is New
- Metabolic Aspects of Polycystic Ovary Syndrome
- Syndrome des ovaires polykystiques : Point de vue contemporain
- Analyzing the role of ACE2, AR, MX1 and TMPRSS2 genetic markers for COVID-19 severity
- Correlation Between Nongenomic Action of C19-Steroids and COVID-19 Severity
- Síndrome de ovario poliquístico: la distancia anogenital como marcador del entorno androgénico prenatal y revisión y comparación de los criterios diagnósticos
- Secondary amenorrhea
- Ethno-medico-botanical claims of Bondla wildlife sanctuary vicinity of Goa
- Spontaneous Lesions of Endangered Geriatric Julia Creek Dunnarts (Sminthopsis douglasi, Archer 1979) with Emphasis in Reproductive Pathology
- Part Three (Cure Most Diseases by Logical Nutrition Treatment): The Society Agent Simulating (SAS) & Usage of Oral and Dental Diseases to Predict Criminals Earlier
- Development of polycystic ovary syndrome: involvement of genetic and environmental factors
- Natural Molecules in the Management of Polycystic Ovary Syndrome (PCOS): An Analytical Review
- Congenital adrenal hyperplasia
- Understanding Polycystic Ovary Syndrome
- Comparison of Clinical and Biochemical Markers of Hirsutism in Polycystic Ovary Syndrome – A Study from a Teaching Hospital in Sri Ramachandra Institute, Chennai, India
- Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
- Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth
- Endocrinology of Transgender Medicine
- An Update of Congenital Adrenal Hyperplasia
- Obesity and polycystic ovary syndrome
- Non-Contraceptive Benefits of Oral Hormonal Contraceptives
- Polycystic ovary syndrome and impact on health
- Polycystic ovary syndrome: insight into pathogenesis and a common association with insulin resistance
- Ovarian Hypertension: Polycystic Ovary Syndrome
- Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome
- Are sex discordant outcomes in COVID-19 related to sex hormones?
- Polycystic ovary syndrome (PCOS)
- Intraovarian vascular enhancement via stromal injection of platelet-derived growth factors: Exploring subsequent oocyte chromosomal status and in vitro fertilization outcomes
- Cross-sex hormone therapy for gender dysphoria
- Oriental herbal medicine and moxibustion for polycystic ovary syndrome